CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- Open-market buys, last 90 days
- $5,000,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$5,000,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-31 | White Mark K. Director | Conversion · Series A Preferred Stock | −48,500 | 0 | ||
| 2020-01-31 | White Mark K. Director | Conversion · Convertible Note | −3,252 | $4.80 | $16K | 0 |
Page 8 of 8 · 142 trades